Clinical trial
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg…
NCT00349375 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00349375 |
|---|---|
| Title | Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy |
| Official title | A Multicenter, Double-Blind, Randomized, Active Comparator, Forced-Titration Study to Compare the Efficacy and Safety of the Combination of 145 mg Fenofibrate and 20 or 40 mg Simvastatin With 40 mg Simvastatin Monotherapy in Patients With Mixed Dyslipidemia at Risk of Cardiovascular Disease Not… |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Fenofibrate/Simvastatin, Simvastatin |
| Enrollment | 1,040 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 7, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | Czechia, Denmark, France, Germany, Hungary, Netherlands, Poland, Ukraine |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: